| __timestamp | Catalyst Pharmaceuticals, Inc. | Soleno Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 10117774 | 2242216 |
| Thursday, January 1, 2015 | 11801342 | 4536244 |
| Friday, January 1, 2016 | 11369941 | 5184803 |
| Sunday, January 1, 2017 | 11375237 | 3068742 |
| Monday, January 1, 2018 | 19919204 | 7178000 |
| Tuesday, January 1, 2019 | 18842752 | 16267000 |
| Wednesday, January 1, 2020 | 16496715 | 23191000 |
| Friday, January 1, 2021 | 16936000 | 21453000 |
| Saturday, January 1, 2022 | 19789000 | 15265000 |
| Sunday, January 1, 2023 | 93150000 | 25189000 |
Data in motion
In the ever-evolving pharmaceutical industry, research and development (R&D) spending is a key indicator of a company's commitment to innovation. Over the past decade, Catalyst Pharmaceuticals, Inc. and Soleno Therapeutics, Inc. have demonstrated varying levels of investment in R&D, reflecting their strategic priorities.
From 2014 to 2023, Catalyst Pharmaceuticals has shown a remarkable increase in R&D spending, culminating in a 830% rise by 2023. This surge underscores their aggressive pursuit of new therapies and market expansion. In contrast, Soleno Therapeutics, while also increasing their R&D budget, has maintained a more steady growth, with a peak in 2023 that is approximately 11 times their 2014 expenditure.
This data highlights the dynamic nature of pharmaceutical innovation, where strategic investments in R&D can significantly impact a company's competitive edge and potential for groundbreaking discoveries.
Research and Development Investment: Johnson & Johnson vs Catalyst Pharmaceuticals, Inc.
Comparing Innovation Spending: Gilead Sciences, Inc. and Catalyst Pharmaceuticals, Inc.
Comparing Innovation Spending: Regeneron Pharmaceuticals, Inc. and Soleno Therapeutics, Inc.
Research and Development Investment: Genmab A/S vs Soleno Therapeutics, Inc.
R&D Insights: How Bio-Techne Corporation and Catalyst Pharmaceuticals, Inc. Allocate Funds
Research and Development Investment: Pharming Group N.V. vs Catalyst Pharmaceuticals, Inc.
Research and Development Expenses Breakdown: Grifols, S.A. vs Catalyst Pharmaceuticals, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Corcept Therapeutics Incorporated and Catalyst Pharmaceuticals, Inc.
Comparing Innovation Spending: CymaBay Therapeutics, Inc. and Catalyst Pharmaceuticals, Inc.
Research and Development Investment: Soleno Therapeutics, Inc. vs Geron Corporation
R&D Spending Showdown: Soleno Therapeutics, Inc. vs Amphastar Pharmaceuticals, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Soleno Therapeutics, Inc. and Xencor, Inc.